Wells Fargo & Company »

Virpax Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Virpax Pharmaceuticals shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Virpax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Virpax Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Virpax Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $20 67 0.31
2023-09-30 $50 63 0.79
2023-06-30 $66 62 1.08
2022-12-31 $36 59 0.63
2022-09-30 $0 58 0.00
2022-06-30 $0 57 0.00
2022-03-31 $0 53 0.00
2021-12-31 $0 52 0.00
2021-09-30 $0 552 0.00
2021-06-30 $0 11 0.00